A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia
IntroductionDementias, including those caused by Alzheimer's Disease (AD), are a leading global cause of death, necessitating improvements in early detection and development of more effective disease-modifying therapies. Well-validated pen-and-paper measures serve as the primary method used for cogn...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2026-06-01
|
| Saila: | Frontiers in Digital Health |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.frontiersin.org/articles/10.3389/fdgth.2026.1840966/full |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
